PAPER Sumien N, Wells MS, Sidhu A, Wong JM, Forster MJ, Zheng QX, Kelleher-Andersson JA

Novel pharmacotherapy: NNI-362, an allosteric p70S6 kinase stimulator, reverses cognitive and neural regenerative deficits in models of aging and disease.

Stem Cell Res Ther. 2021 Jan 13;12(1):59. PubMed: 33436007

PAPER Calsolaro V, Bottari M, Coppini G, Lemmi B, Monzani F

Endocrine dysfunction and cognitive impairment.

Minerva Endocrinol. 2021 Jan 12; PubMed: 33435644

PAPER Gad HA, Mamadalieva NZ, Böhmdorfer S, Rosenau T, Zengin G, Mamadalieva RZ, Musayeib NM, Ashour ML

GC-MS Based Identification of the Volatile Components of Six Astragalus Species from Uzbekistan and Their Biological Activity.

Plants (Basel). 2021 Jan 8;10(1) PubMed: 33435616

PAPER Siedlecki-Wullich D, Miñano-Molina AJ, Rodríguez-Álvarez J

microRNAs as Early Biomarkers of Alzheimer's Disease: A Synaptic Perspective.

Cells. 2021 Jan 9;10(1) PubMed: 33435363

PAPER Pandey PK, Sharma AK, Rani S, Mishra G, Kandasamy G, Patra AK, Rana M, Sharma AK, Yadav AK, Gupta U

MCM-41 Nanoparticles for Brain Delivery: Better Choline-Esterase and Amyloid Formation Inhibition with Improved Kinetics.

ACS Biomater Sci Eng. 2018 Aug 13;4(8):2860-2869. Epub 2018 Jul 25 PubMed: 33435009

PAPER Lissek V, Suchan B

Preventing dementia? Interventional approaches in mild cognitive impairment.

Neurosci Biobehav Rev. 2021 Mar;122:143-164. Epub 2021 Jan 10 PubMed: 33440197

PAPER Ju S, Seo JY, Lee SK, Oh J, Kim JS

Oral administration of hydrolyzed red ginseng extract improves learning and memory capability of scopolamine-treated C57BL/6J mice via upregulation of Nrf2-mediated antioxidant mechanism.

J Ginseng Res. 2021 Jan;45(1):108-118. Epub 2019 Dec 20 PubMed: 33437162

PAPER Tijms BM, Gobom J, Reus L, Jansen I, Hong S, Dobricic V, Kilpert F, Ten Kate M, Barkhof F, Tsolaki M, Verhey FR, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Molinuevo JL, Engelborghs S, Bertram L, Lovestone S, Streffer J, Vos S, Bos I, Alzheimer’s Disease Neuroimaging Initiative (ADNI), Blennow K, Scheltens P, Teunissen CE, Zetterberg H, Visser PJ

Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.

Brain. 2020 Dec 1;143(12):3776-3792. PubMed: 33439986

Lea T. Grinberg on A novel temporal-predominant neuro-astroglial tauopathy associated with TMEM106B gene polymorphism in FTLD/ALS-TDP.

COMMENT In frontotemporal dementia, tau and TDP43 rarely appear together. People with #FTLD-TDP and TMEM106B polymorphism A/A have an odds ratio of 13.9 (crude) or 31.3 (multivariate) to develop a distinct 4R tauopathy. We investigated 90 FTLD-TDP cases—all types

Expression Analysis Uncovers Three Distinct Forms of Alzheimer’s

RESEARCH NEWS 2021-01-14 Research News Alzheimer’s disease comes in distinct molecular flavors, according to a study in the January 6 Science Advances. Researchers led by Bin Zhang at Icahn School of Medicine at Mount Sinai, New York, compared bulk RNA-Seq data from AD and contro

PAPER

Human genome meeting 2016: Houston, TX, USA. 28 February- 2 March 2016.

Hum Genomics. 2016 May 26;10 Suppl 1:12. PubMed: 27294413

Neuro> 2021: The CurePSP International Research Symposium (Virtual Meeting)

CONFERENCE 2021-02-04 00:00:00-2021-02-05 00:00:00 Online Meeting 04 February 2021 to 05 February 2021 View Conference Website 0

SEARCH RESULTS